Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	benzodiazepine receptor binding	RIMBP3 RIMBP3C RIMBP3B	3.13e-06	5	137	3	GO:0030156
GeneOntologyBiologicalProcess	regulation of microtubule depolymerization	MAP1A APC2 KATNB1 CAMSAP3 GAS2L1 MAP1S	3.04e-07	42	135	6	GO:0031114
GeneOntologyBiologicalProcess	regulation of microtubule polymerization or depolymerization	MAP1A MAPT APC2 KATNB1 CAMSAP3 GAS2L1 MAP1S INPP5J	5.55e-07	108	135	8	GO:0031110
GeneOntologyBiologicalProcess	negative regulation of microtubule polymerization or depolymerization	MAP1A APC2 KATNB1 CAMSAP3 GAS2L1 INPP5J	9.94e-07	51	135	6	GO:0031111
GeneOntologyBiologicalProcess	regulation of supramolecular fiber organization	MAP1A MAPT APC2 KATNB1 CAMSAP3 TRIOBP PLEKHG2 TESK1 MEF2C ARHGEF15 GAS2L1 KANK1 MAP1S INPP5J	1.14e-06	438	135	14	GO:1902903
GeneOntologyBiologicalProcess	regulation of microtubule cytoskeleton organization	MAP1A MAPT APC2 KATNB1 CAMSAP3 GAS2L1 PHLDB1 MAP1S INPP5J	2.43e-06	176	135	9	GO:0070507
GeneOntologyBiologicalProcess	microtubule depolymerization	MAP1A APC2 KATNB1 CAMSAP3 GAS2L1 MAP1S	4.63e-06	66	135	6	GO:0007019
GeneOntologyBiologicalProcess	negative regulation of microtubule depolymerization	MAP1A APC2 KATNB1 CAMSAP3 GAS2L1	4.71e-06	38	135	5	GO:0007026
GeneOntologyBiologicalProcess	regulation of protein depolymerization	MAP1A APC2 KATNB1 CAMSAP3 TRIOBP GAS2L1 MAP1S	5.88e-06	105	135	7	GO:1901879
GeneOntologyBiologicalProcess	regulation of cytoskeleton organization	MAP1A MAPT APC2 KATNB1 CAMSAP3 TRIOBP PLEKHG2 TESK1 MEF2C ARHGEF15 GAS2L1 PHLDB1 KANK1 MAP1S INPP5J	6.11e-06	579	135	15	GO:0051493
GeneOntologyBiologicalProcess	microtubule polymerization or depolymerization	MAP1A MAPT APC2 KATNB1 CAMSAP3 GAS2L1 MAP1S INPP5J	1.51e-05	168	135	8	GO:0031109
GeneOntologyBiologicalProcess	negative regulation of protein depolymerization	MAP1A APC2 KATNB1 CAMSAP3 TRIOBP GAS2L1	2.62e-05	89	135	6	GO:1901880
GeneOntologyBiologicalProcess	negative regulation of cytoskeleton organization	MAP1A APC2 KATNB1 CAMSAP3 TRIOBP GAS2L1 KANK1 INPP5J	4.24e-05	194	135	8	GO:0051494
GeneOntologyBiologicalProcess	protein depolymerization	MAP1A APC2 KATNB1 CAMSAP3 TRIOBP GAS2L1 MAP1S	4.59e-05	144	135	7	GO:0051261
GeneOntologyBiologicalProcess	regulation of protein-containing complex disassembly	MAP1A APC2 KATNB1 CAMSAP3 TRIOBP GAS2L1 MAP1S	4.59e-05	144	135	7	GO:0043244
GeneOntologyBiologicalProcess	negative regulation of supramolecular fiber organization	MAP1A APC2 KATNB1 CAMSAP3 TRIOBP GAS2L1 KANK1 INPP5J	4.73e-05	197	135	8	GO:1902904
GeneOntologyBiologicalProcess	negative regulation of protein-containing complex disassembly	MAP1A APC2 KATNB1 CAMSAP3 TRIOBP GAS2L1	5.06e-05	100	135	6	GO:0043242
GeneOntologyBiologicalProcess	regulation of organelle organization	MAP1A MAPT APC2 KATNB1 CAMSAP3 TRIOBP CUL9 PLEKHG2 TESK1 INO80D MEF2C ARHGEF15 GAS2L1 PHLDB1 CAMKK2 KANK1 MAP1S YLPM1 NFRKB SEC16A ERC2 INPP5J	5.88e-05	1342	135	22	GO:0033043
GeneOntologyBiologicalProcess	neuromuscular synaptic transmission	RIMBP3 ERC2 RIMBP3C RIMBP3B	8.79e-05	36	135	4	GO:0007274
GeneOntologyBiologicalProcess	heart development	ADAM19 FN1 HCN4 NACA ZFPM1 KDM6B MEF2C RBM20 LDB3 GLI1 DCHS1 CC2D2A LTBP1 PCNT SOS1	1.33e-04	757	135	15	GO:0007507
GeneOntologyBiologicalProcess	regulation of microtubule-based process	MAP1A MAPT APC2 KATNB1 CAMSAP3 GAS2L1 PHLDB1 MAP1S INPP5J	1.37e-04	293	135	9	GO:0032886
GeneOntologyBiologicalProcess	embryo development	FN1 HCN4 CAMSAP3 TRIOBP ZFPM1 KDM6B BIRC6 INO80D MEF2C BAP1 PHLDB1 KMT2D NKD1 SH3PXD2A GLI1 ARMC5 NFRKB DCHS1 CC2D2A GNAS PCNT SOS1	1.59e-04	1437	135	22	GO:0009790
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization	MAP1A MAPT APC2 KATNB1 CAMSAP3 CUL9 GAS2L1 PHLDB1 MAP7D1 MAP1S CC2D2A LSM14A INPP5J PCNT	2.72e-04	720	135	14	GO:0000226
GeneOntologyBiologicalProcess	mitral valve formation	ZFPM1 DCHS1	4.20e-04	5	135	2	GO:0003192
GeneOntologyBiologicalProcess	P-body assembly	PATL1 ATXN2 LSM14A	4.41e-04	23	135	3	GO:0033962
GeneOntologyBiologicalProcess	negative regulation of organelle organization	MAP1A MAPT APC2 KATNB1 CAMSAP3 TRIOBP TESK1 GAS2L1 KANK1 INPP5J	4.61e-04	421	135	10	GO:0010639
GeneOntologyCellularComponent	MLL3/4 complex	KDM6B KMT2C KMT2D	5.55e-05	12	135	3	GO:0044666
GeneOntologyCellularComponent	microtubule	KIF21B MAP1A MAPT APC2 KATNB1 CAMSAP3 GAS2L1 SHROOM1 MAP1S CEP170B CSTPP1 PCNT	1.80e-04	533	135	12	GO:0005874
MousePheno	abnormal heart atrium morphology	PABIR1 ADAM19 MEF2C RBM20 SH3PXD2A DCHS1 CC2D2A LTBP1 PCNT SOS1	2.29e-05	232	116	10	MP:0003105
MousePheno	abnormal interatrial septum morphology	ADAM19 SH3PXD2A DCHS1 CC2D2A LTBP1 PCNT SOS1	2.97e-05	107	116	7	MP:0000282
Domain	SH3	CASS4 TRIO RIMBP3 CASKIN2 SH3PXD2A MAP3K10 RIMBP3C EPS8L3 RIMBP3B	2.47e-05	216	133	9	SM00326
Domain	SH3	CASS4 TRIO RIMBP3 CASKIN2 SH3PXD2A MAP3K10 RIMBP3C EPS8L3 RIMBP3B	2.47e-05	216	133	9	PS50002
Domain	SH3_domain	CASS4 TRIO RIMBP3 CASKIN2 SH3PXD2A MAP3K10 RIMBP3C EPS8L3 RIMBP3B	2.85e-05	220	133	9	IPR001452
Domain	Med13_N	MED13L MED13	5.03e-05	2	133	2	PF11597
Domain	Mediator_Med13_N_met/fun	MED13L MED13	5.03e-05	2	133	2	IPR021643
Domain	Med13_C	MED13L MED13	5.03e-05	2	133	2	PF06333
Domain	Mediator_Med13	MED13L MED13	5.03e-05	2	133	2	IPR009401
Domain	DH_1	TRIO PLEKHG2 ARHGEF17 ARHGEF15 SOS1	8.57e-05	63	133	5	PS00741
Domain	RhoGEF	TRIO PLEKHG2 ARHGEF17 ARHGEF15 SOS1	1.24e-04	68	133	5	SM00325
Domain	RhoGEF	TRIO PLEKHG2 ARHGEF17 ARHGEF15 SOS1	1.42e-04	70	133	5	PF00621
Domain	DH_2	TRIO PLEKHG2 ARHGEF17 ARHGEF15 SOS1	1.42e-04	70	133	5	PS50010
Domain	FAM122	PABIR1 PABIR2	1.50e-04	3	133	2	IPR026716
Domain	MAP1	MAP1A MAP1S	1.50e-04	3	133	2	IPR026074
Domain	-	TRIO PLEKHG2 ARHGEF17 ARHGEF15 SOS1	1.52e-04	71	133	5	1.20.900.10
Domain	DH-domain	TRIO PLEKHG2 ARHGEF17 ARHGEF15 SOS1	1.52e-04	71	133	5	IPR000219
Domain	SH3_9	CASS4 RIMBP3 MAP3K10 RIMBP3C RIMBP3B	2.36e-04	78	133	5	PF14604
Domain	SH3_2	RIMBP3 CASKIN2 MAP3K10 RIMBP3C RIMBP3B	3.73e-04	86	133	5	PF07653
Domain	SH3_2	RIMBP3 CASKIN2 MAP3K10 RIMBP3C RIMBP3B	3.73e-04	86	133	5	IPR011511
Domain	FYrich_C	KMT2C KMT2D	4.96e-04	5	133	2	IPR003889
Domain	FYrich_N	KMT2C KMT2D	4.96e-04	5	133	2	IPR003888
Domain	FYRC	KMT2C KMT2D	4.96e-04	5	133	2	SM00542
Domain	FYRN	KMT2C KMT2D	4.96e-04	5	133	2	SM00541
Domain	FYRN	KMT2C KMT2D	4.96e-04	5	133	2	PF05964
Domain	FYRC	KMT2C KMT2D	4.96e-04	5	133	2	PF05965
Domain	FYRC	KMT2C KMT2D	4.96e-04	5	133	2	PS51543
Domain	FYRN	KMT2C KMT2D	4.96e-04	5	133	2	PS51542
Domain	FN3	FN1 IGDCC4 RIMBP3 FNDC1 RIMBP3C RIMBP3B LRIT1	5.63e-04	199	133	7	PS50853
Domain	FN3_dom	FN1 IGDCC4 RIMBP3 FNDC1 RIMBP3C RIMBP3B LRIT1	7.52e-04	209	133	7	IPR003961
Domain	PH_dom-like	TRIO PLEKHA4 TRIOBP PLEKHG2 ARHGEF17 ARHGEF15 PHLDB1 EPS8L3 AGAP3 SOS1	9.56e-04	426	133	10	IPR011993
Domain	APC_su10/DOC_dom	CUL9 ZZEF1	1.03e-03	7	133	2	IPR004939
Domain	DOC	CUL9 ZZEF1	1.03e-03	7	133	2	PS51284
Domain	ANAPC10	CUL9 ZZEF1	1.03e-03	7	133	2	PF03256
Domain	APC10	CUL9 ZZEF1	1.03e-03	7	133	2	SM01337
Domain	PH	TRIO PLEKHA4 TRIOBP PLEKHG2 PHLDB1 AGAP3 SOS1	1.28e-03	229	133	7	PF00169
Domain	DUF1669	FAM83H FAM83B	1.37e-03	8	133	2	PF07894
Domain	DUF1669	FAM83H FAM83B	1.37e-03	8	133	2	IPR012461
Domain	FN3	FN1 IGDCC4 FNDC1 RIMBP3C RIMBP3B LRIT1	2.11e-03	185	133	6	SM00060
Pathway	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING	TRIO RELA PLEKHG2 ARHGEF17 ARHGEF15 SOS1	9.09e-06	85	81	6	MM14746
Pathway	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	TRIO PLEKHG2 ARHGEF17 ARHGEF15 SOS1	1.16e-05	52	81	5	MM14743
Pathway	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING	TRIO RELA PLEKHG2 ARHGEF17 ARHGEF15 SOS1	1.94e-05	97	81	6	M9400
Pathway	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	TRIO PLEKHG2 ARHGEF17 ARHGEF15 SOS1	2.17e-05	59	81	5	M11215
Pathway	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE	TRIO PLEKHG2 ARHGEF17 ARHGEF15 SOS1	4.99e-05	70	81	5	MM14824
Pathway	REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE	TRIO PLEKHG2 ARHGEF17 ARHGEF15 SOS1	7.42e-05	76	81	5	M19832
Pathway	REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS	TRIO PLEKHG2 ARHGEF17 ARHGEF15 SOS1	7.90e-05	77	81	5	MM15044
Pathway	REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS	TRIO PLEKHG2 ARHGEF17 ARHGEF15 SOS1	9.49e-05	80	81	5	M800
Pathway	REACTOME_DEATH_RECEPTOR_SIGNALING	TRIO RELA PLEKHG2 ARHGEF17 ARHGEF15 SOS1	1.64e-04	142	81	6	MM15431
Pathway	REACTOME_DEATH_RECEPTOR_SIGNALING	TRIO RELA PLEKHG2 ARHGEF17 ARHGEF15 SOS1	2.55e-04	154	81	6	M27697
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PABIR1 SRRM1 HIVEP1 TRIO MAPT PAK4 CAMSAP3 PLEKHG2 ARHGEF17 MAP3K6 TESK1 PABIR2 FAM83H ITPKB FAM83B PHLDB1 MAP7D1 FAM117A CASKIN2 SH3PXD2A SEC16A MAP3K10 GNAS SRRM2 RGL2 CEP170B AGAP3	1.63e-16	861	142	27	36931259
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TRIO SZT2 CUL9 ZFPM1 MED13L KDM6B FHIP1B ZZEF1 TESK1 BIRC6 FAM83H BAP1 ORC1 GAS2L1 KMT2C PHLDB1 KMT2D PNPLA6 MAP1S EPOP GLI1 SEC16A CACNA1H SNX11 RGL2 MED13 CEP170B PCNT AGAP3	1.12e-15	1105	142	29	35748872
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CUL9 CAMTA2 MED13L FHIP1B ARHGEF17 IGDCC4 PHLDB1 MAP7D1 CAMKK2 KANK1 TENM3 SEC16A ERC2 CACNA1H SRRM2 CEP170B PCNT	1.10e-12	407	142	17	12693553
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	SRRM1 HIVEP1 SRSF7 MAPT NELFA CAMSAP3 BUD13 PATL1 ZFPM1 BAP1 KMT2D PNPLA6 MAP1S YLPM1 NFRKB SEC16A PPP1R18 SRRM2 MED13 SOS1	6.15e-11	774	142	20	15302935
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	TRIOBP MED13L BIRC6 ARHGEF15 BAP1 KMT2C PHLDB1 CAMKK2 SEC16A ERC2 RPRD2 PCNT	1.66e-10	225	142	12	12168954
Pubmed	Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.	SRRM1 SRSF7 KATNB1 GAS2L1 PHLDB1 ATXN2 CASKIN2 SRRM2	1.58e-08	108	142	8	19531213
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KIF21B SZT2 PAK4 NACA TRIOBP KDM6B ZZEF1 BAP1 KMT2C CAMKK2 CASKIN2 RPRD2 HHIPL1 MED13	4.05e-08	529	142	14	14621295
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	PABIR1 CBLL1 KIF21B SRRM1 SZT2 NELFA PATL1 MED13L BIRC6 INO80D BAP1 KMT2C EPOP ARMC5 YLPM1 NFRKB SEC16A LTBP1 MED13 PCNT SOS1	1.12e-07	1327	142	21	32694731
Pubmed	Transcriptome of the inner circular smooth muscle of the developing mouse intestine: Evidence for regulation of visceral smooth muscle genes by the hedgehog target gene, cJun.	ADAM19 FN1 MAPT MEF2C NKD1 GLI1 CACNA1H LTBP1	1.20e-07	140	142	8	26930384
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	SRRM1 MAP1A MAPT CAMSAP3 XKR4 CAMKK2 SH3PXD2A ERC2 SRRM2 CEP170B SOS1	2.07e-07	347	142	11	17114649
Pubmed	Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library.	RIMBP3 RIMBP3C RIMBP3B ZNF541	2.58e-07	14	142	4	17662146
Pubmed	RIM-BP3 is a manchette-associated protein essential for spermiogenesis.	RIMBP3 RIMBP3C RIMBP3B	2.66e-07	4	142	3	19091768
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	PABIR1 TRIO PAK4 CAMSAP3 TRIOBP RELA BIRC6 PABIR2 RBM20 KMT2D ATXN2 CASKIN2 YLPM1 SEC16A PPP1R18 LTBP1 SRRM2 PCNT	3.06e-07	1049	142	18	27880917
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CBLL1 KIF21B TRIO HCN4 APC2 CAMSAP3 TRIOBP SHISA7 MAP7D1 ATXN2 YLPM1 SEC16A DCHS1 ERC2 UNC79 CEP170B PCNT	4.53e-07	963	142	17	28671696
Pubmed	Mutation of ARHGAP9 in patients with coronary spastic angina.	TRIO PLEKHG2 ARHGEF17 ARHGEF15 SOS1	4.76e-07	38	142	5	19911011
Pubmed	Structure and evolution of RIM-BP genes: identification of a novel family member.	RIMBP3 RIMBP3C RIMBP3B	6.62e-07	5	142	3	17855024
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SRRM1 MAP1A MAPT CUL9 BUD13 RSRC2 ZZEF1 INO80D FAM83H ZNF469 MAP7D1 PNPLA6 NFRKB SEC16A SRRM2 CEP170B AGAP3 SOS1	7.48e-07	1116	142	18	31753913
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	CBLL1 PDK3 NACA CAMSAP3 TRIOBP BUD13 RELA RSRC2 INO80D FAM83B ORC1 KMT2C MAP7D1 PNPLA6 ATXN2 NFRKB PPP1R18 LSM14A MED13 CEP170B AGAP3	8.00e-07	1497	142	21	31527615
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	KIF21B SRSF7 ZZEF1 ZNF469 PHLDB1 TENM3 CACNA1H PCNT	1.09e-06	187	142	8	26460568
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	HIVEP1 NELFA MED13L BAP1 KMT2D YLPM1 NFRKB RPRD2 MED13	1.71e-06	268	142	9	33640491
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	CBLL1 SRRM1 SRSF7 CAMSAP3 TRIOBP FAM83B MAP7D1 PPP1R18 RPRD2 SRRM2	2.53e-06	361	142	10	30344098
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	HIVEP1 FN1 APC2 PLEKHA4 TRIOBP VWCE PHLDB1 CACTIN-AS1 RPRD2 LSM14A LTBP1 AGAP3	3.53e-06	560	142	12	21653829
Pubmed	Essential roles of Meltrin beta (ADAM19) in heart development.	ADAM19 FN1 LTBP1	3.68e-06	8	142	3	14975714
Pubmed	Human transcription factor protein interaction networks.	HIVEP1 NACA CUL9 RELA PATL1 INO80D MEF2C RBM20 BAP1 KMT2C MAP7D1 KMT2D ATXN2 YLPM1 NFRKB SEC16A RPRD2 LSM14A SRRM2	6.08e-06	1429	142	19	35140242
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	FN1 SRSF7 MAP1A TRIO MAPT CAMSAP3 ARHGEF17 ITPKB GAS2L1 PHLDB1 MAP7D1 PNPLA6 MAP1S SEC16A SORCS2 PPP1R18 ERC2 CEP170B AGAP3	6.21e-06	1431	142	19	37142655
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	HIVEP1 CAMSAP3 BIRC6 RBM20 BAP1 MAP7D1 KMT2D SEC16A CSTPP1 PCNT	9.17e-06	418	142	10	34709266
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ABCC4 TRIO MAPT CAMSAP3 TRIOBP PATL1 ITPKB KMT2C PHLDB1 PNPLA6 ATXN2 SH3PXD2A RPRD2 CACNA1H LSM14A GNAS CEP170B PCNT AGAP3	1.09e-05	1489	142	19	28611215
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	MAP1A KMT2D NFRKB SEC16A RPRD2 CEP170B CSTPP1	1.13e-05	184	142	7	32908313
Pubmed	Cyclic AMP-dependent protein kinase regulates 9G8-mediated alternative splicing of tau exon 10.	SRSF7 MAPT	1.66e-05	2	142	2	22677170
Pubmed	Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease.	TICAM1 SOS1	1.66e-05	2	142	2	15767257
Pubmed	Isoform-selective interaction of the adaptor protein Tks5/FISH with Sos1 and dynamins.	SH3PXD2A SOS1	1.66e-05	2	142	2	19464300
Pubmed	KMT2C/D COMPASS complex-associated diseases [KCDCOM-ADs]: an emerging class of congenital regulopathies.	KMT2C KMT2D	1.66e-05	2	142	2	31924266
Pubmed	Expression of the GTP-binding protein (Galphas) is repressed by the nuclear factor kappaB RelA subunit in human myometrium.	RELA GNAS	1.66e-05	2	142	2	16081638
Pubmed	The SRm160/300 splicing coactivator subunits.	SRRM1 SRRM2	1.66e-05	2	142	2	10668804
Pubmed	Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability.	KMT2C KMT2D	1.66e-05	2	142	2	28967912
Pubmed	Spatiotemporal regulation of an Hcn4 enhancer defines a role for Mef2c and HDACs in cardiac electrical patterning.	HCN4 MEF2C	1.66e-05	2	142	2	23085412
Pubmed	Association of KMT2C/D loss-of-function variants with response to immune checkpoint blockades in colorectal cancer.	KMT2C KMT2D	1.66e-05	2	142	2	36601880
Pubmed	Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation.	KMT2C KMT2D	1.66e-05	2	142	2	28483418
Pubmed	Mediator complex component MED13 regulates zygotic genome activation and is required for postimplantation development in the mouse.	MED13L MED13	1.66e-05	2	142	2	29325037
Pubmed	Inactivation of a Gα(s)-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis.	GLI1 GNAS	1.66e-05	2	142	2	25961504
Pubmed	The PTH-Gαs-protein kinase A cascade controls αNAC localization to regulate bone mass.	NACA GNAS	1.66e-05	2	142	2	24550008
Pubmed	The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape.	KMT2C KMT2D	1.66e-05	2	142	2	34156443
Pubmed	Heterotrimeric G protein Gαs subunit attenuates PLEKHG2, a Rho family-specific guanine nucleotide exchange factor, by direct interaction.	PLEKHG2 GNAS	1.66e-05	2	142	2	28108261
Pubmed	Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma.	KMT2C KMT2D	1.66e-05	2	142	2	27280393
Pubmed	Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils.	FN1 LTBP1	1.66e-05	2	142	2	8756760
Pubmed	Loss of MLL3/4 decouples enhancer H3K4 monomethylation, H3K27 acetylation, and gene activation during embryonic stem cell differentiation.	KMT2C KMT2D	1.66e-05	2	142	2	36869380
Pubmed	Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-κB is associated with a poor prognosis of pancreatic cancer.	RELA GLI1	1.66e-05	2	142	2	23860225
Pubmed	KDM6B cooperates with Tau and regulates synaptic plasticity and cognition via inducing VGLUT1/2.	MAPT KDM6B	1.66e-05	2	142	2	36028572
Pubmed	Tau-tubulin kinase 1 enhances prefibrillar tau aggregation and motor neuron degeneration in P301L FTDP-17 tau-mutant mice.	MAPT TTBK1	1.66e-05	2	142	2	20354135
Pubmed	Acute inhibition of the CNS-specific kinase TTBK1 significantly lowers tau phosphorylation at several disease relevant sites.	MAPT TTBK1	1.66e-05	2	142	2	32255788
Pubmed	Crucial roles of mixed-lineage leukemia 3 and 4 as epigenetic switches of the hepatic circadian clock controlling bile acid homeostasis in mice.	KMT2C KMT2D	1.66e-05	2	142	2	25346535
Pubmed	Geraniin suppresses ovarian cancer growth through inhibition of NF-κB activation and downregulation of Mcl-1 expression.	MCL1 RELA	1.66e-05	2	142	2	28590547
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	SRRM1 HIVEP1 SRSF7 BUD13 PHLDB1 MAP7D1 SHROOM1 MAP1S SRRM2	1.88e-05	361	142	9	26167880
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	NACA TRIOBP BUD13 PATL1 FAM83H BAP1 FAM83B ORC1 MAP7D1 KANK1 MAP1S YLPM1 PPP1R18 LSM14A GNAS CEP170B	2.13e-05	1155	142	16	20360068
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	SRRM1 TRIO PAK4 NACA CAMSAP3 PLEKHG2 ARHGEF17 ARHGEF15 MAP7D1 SH3PXD2A SEC16A LSM14A AGAP3 SOS1	2.49e-05	916	142	14	32203420
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	HIVEP1 MAP1A CUL9 RBM20 FAM83B RIMBP3 SEC16A ERC2 GNAS CEP170B PCNT	3.19e-05	588	142	11	38580884
Pubmed	WW domains provide a platform for the assembly of multiprotein networks.	SRRM1 SRSF7 MAP1S YLPM1 RPRD2 SRRM2	4.26e-05	154	142	6	16055720
Pubmed	Calcium handling precedes cardiac differentiation to initiate the first heartbeat.	HCN4 MEF2C CACNA1H	4.35e-05	17	142	3	27725084
Pubmed	Structural Basis of Formation of the Microtubule Minus-End-Regulating CAMSAP-Katanin Complex.	KATNB1 CAMSAP3	4.95e-05	3	142	2	29395789
Pubmed	Long non-coding RNA DBH-AS1 promotes cancer progression in diffuse large B-cell lymphoma by targeting FN1 via RNA-binding protein BUD13.	FN1 BUD13	4.95e-05	3	142	2	32091157
Pubmed	Tau-tubulin kinase 1 (TTBK1), a neuron-specific tau kinase candidate, is involved in tau phosphorylation and aggregation.	MAPT TTBK1	4.95e-05	3	142	2	16923168
Pubmed	NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit.	RELA NFRKB	4.95e-05	3	142	2	2050119
Pubmed	Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription.	KMT2C KMT2D	4.95e-05	3	142	2	23932714
Pubmed	Mutations of PTCH1, MLL2, and MLL3 are not frequent events in hepatoblastoma.	KMT2C KMT2D	4.95e-05	3	142	2	22183980
Pubmed	SFRS7-mediated splicing of tau exon 10 is directly regulated by STOX1A in glial cells.	SRSF7 MAPT	4.95e-05	3	142	2	21755018
Pubmed	Specific activation of PLEKHG2-induced serum response element-dependent gene transcription by four-and-a-half LIM domains (FHL) 1, but not FHL2 or FHL3.	PLEKHG2 GNAS	4.95e-05	3	142	2	28489964
Pubmed	N-α-acetyltransferase 10 protein inhibits apoptosis through RelA/p65-regulated MCL1 expression.	MCL1 RELA	4.95e-05	3	142	2	22496479
Pubmed	HOXC6 Is transcriptionally regulated via coordination of MLL histone methylase and estrogen receptor in an estrogen environment.	KMT2C KMT2D	4.95e-05	3	142	2	21683083
Pubmed	Testosterone enhances cardiomyogenesis in stem cells and recruits the androgen receptor to the MEF2C and HCN4 genes.	HCN4 MEF2C	4.95e-05	3	142	2	23598283
Pubmed	MLL2 promotes cancer cell lymph node metastasis by interacting with RelA and facilitating STC1 transcription.	RELA KMT2D	4.95e-05	3	142	2	31676369
Pubmed	The in vivo regulation of heart rate in the murine sinoatrial node by stimulatory and inhibitory heterotrimeric G proteins.	HCN4 GNAS	4.95e-05	3	142	2	23697798
Pubmed	miR-132 loss de-represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain.	MAPT ITPKB	4.95e-05	3	142	2	27485122
Pubmed	MAP3K10 promotes the proliferation and decreases the sensitivity of pancreatic cancer cells to gemcitabine by upregulating Gli-1 and Gli-2.	GLI1 MAP3K10	4.95e-05	3	142	2	23178452
Pubmed	Silencing of SETD6 inhibits the tumorigenesis of oral squamous cell carcinoma by inhibiting methylation of PAK4 and RelA.	PAK4 RELA	4.95e-05	3	142	2	33710605
Pubmed	ROS-induced ZNF580 expression: a key role for H2O2/NF-κB signaling pathway in vascular endothelial inflammation.	RELA ZNF580	4.95e-05	3	142	2	21830064
Pubmed	The fibronectin ED-A domain enhances recruitment of latent TGF-β-binding protein-1 to the fibroblast matrix.	FN1 LTBP1	4.95e-05	3	142	2	29361522
Pubmed	Fibronectin regulates latent transforming growth factor-beta (TGF beta) by controlling matrix assembly of latent TGF beta-binding protein-1.	FN1 LTBP1	4.95e-05	3	142	2	15677465
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	KDM6B ARHGEF17 SEC16A ERC2 SRRM2	7.03e-05	104	142	5	9205841
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	PABIR1 KIF21B SRRM1 MAPT PAK4 NACA SRRM2	7.19e-05	246	142	7	15345747
Pubmed	Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.	BAP1 KMT2C KMT2D	7.22e-05	20	142	3	29785026
Pubmed	Differential regulation of microtubule severing by APC underlies distinct patterns of projection neuron and interneuron migration.	MAPT APC2 KATNB1	7.22e-05	20	142	3	25535916
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	MAP1A APC2 ZNF469 MAP1S ATXN2 YLPM1 TMEM151A PCNT SOS1	7.29e-05	430	142	9	35044719
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ADAM19 FN1 TRIO APC2 TRIOBP CUL9 MED13L KDM6B MAP1S YLPM1 MAP3K10 ERC2 MED13 PCNT AGAP3 SOS1	7.56e-05	1285	142	16	35914814
Pubmed	Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition.	KDM6B KMT2C KMT2D	8.40e-05	21	142	3	27626377
Pubmed	Programmed cell senescence during mammalian embryonic development.	NKD1 GLI1 PCNT	8.40e-05	21	142	3	24238962
Pubmed	MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarity.	MAPT PAK4 MAP1S CEP170B	8.89e-05	57	142	4	29089450
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	NELFA PAK4 BIRC6 FAM83B MAP1S SH3PXD2A SEC16A CEP170B AGAP3	9.62e-05	446	142	9	24255178
Pubmed	Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation.	KMT2C KMT2D	9.88e-05	4	142	2	19221051
Pubmed	Cancer gene mutation frequencies for the U.S. population.	KMT2C KMT2D	9.88e-05	4	142	2	34645806
Pubmed	The acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexes.	SRRM1 SRRM2	9.88e-05	4	142	2	10908574
Pubmed	Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy.	MAPT SOS1	9.88e-05	4	142	2	26077951
Pubmed	Tau activation of microglial cGAS-IFN reduces MEF2C-mediated cognitive resilience.	MAPT MEF2C	9.88e-05	4	142	2	37095396
Pubmed	FBXL19 recruits CDK-Mediator to CpG islands of developmental genes priming them for activation during lineage commitment.	MED13L MED13	9.88e-05	4	142	2	29809150
Pubmed	Identification of novel candidate genes in heterotaxy syndrome patients with congenital heart diseases by whole exome sequencing.	KMT2D GLI1	9.88e-05	4	142	2	32738303
Pubmed	MLL3/MLL4 are required for CBP/p300 binding on enhancers and super-enhancer formation in brown adipogenesis.	KMT2C KMT2D	9.88e-05	4	142	2	28398509
Pubmed	NAP1L1 regulates NF-κB signaling pathway acting on anti-apoptotic Mcl-1 gene expression.	MCL1 RELA	9.88e-05	4	142	2	28687276
Pubmed	miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin.	FN1 FNDC1	9.88e-05	4	142	2	27693493
Pubmed	Cerebral small vessel disease-related protease HtrA1 processes latent TGF-β binding protein 1 and facilitates TGF-β signaling.	FN1 LTBP1	9.88e-05	4	142	2	25369932
Pubmed	A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity.	KMT2C KMT2D	9.88e-05	4	142	2	23129768
Pubmed	miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3β in Alzheimer's disease.	MAPT TTBK1	9.88e-05	4	142	2	30556160
Interaction	YWHAH interactions	PABIR1 KIF21B SRRM1 HIVEP1 FN1 TRIO MAPT PAK4 CAMSAP3 PLEKHA4 PLEKHG2 ARHGEF17 MAP3K6 TESK1 ANKRD55 PABIR2 FAM83H BAP1 FAM83B PHLDB1 MAP7D1 KANK1 SHROOM1 FAM117A GRID2IP CASKIN2 SH3PXD2A SEC16A MAP3K10 CC2D2A SRRM2 RGL2 CEP170B PCNT AGAP3	1.46e-14	1102	139	35	int:YWHAH
Interaction	YWHAG interactions	PABIR1 KIF21B SRRM1 HIVEP1 FN1 MAPT PAK4 CAMSAP3 PLEKHA4 PLEKHG2 ARHGEF17 MAP3K6 TESK1 ANKRD55 PABIR2 FAM83H BAP1 ITPKB FAM83B PHLDB1 MAP7D1 KANK1 SHROOM1 TTBK1 FAM117A GRID2IP CASKIN2 SH3PXD2A SEC16A MAP3K10 GNAS SRRM2 RGL2 CEP170B AGAP3	5.60e-13	1248	139	35	int:YWHAG
Interaction	YWHAB interactions	PABIR1 KIF21B HIVEP1 FN1 MAPT NELFA PAK4 CAMSAP3 PLEKHA4 ARHGEF17 TESK1 ANKRD55 PABIR2 FAM83H BAP1 ITPKB FAM83B PHLDB1 MAP7D1 KANK1 SHROOM1 FAM117A GRID2IP SH3PXD2A MAP3K10 SRRM2 RGL2 CEP170B AGAP3	5.06e-11	1014	139	29	int:YWHAB
Interaction	TOP3B interactions	TRIO SZT2 PLEKHA4 CUL9 PATL1 ZFPM1 MED13L KDM6B FHIP1B ZZEF1 TESK1 BIRC6 FAM83H BAP1 ORC1 GAS2L1 KMT2C PHLDB1 KMT2D PNPLA6 MAP1S EPOP ATXN2 GLI1 SEC16A CACNA1H LSM14A GNAS SNX11 RGL2 MED13 CEP170B PCNT AGAP3	2.47e-10	1470	139	34	int:TOP3B
Interaction	MAPRE3 interactions	MAP1A TRIO MAPT APC2 CAMSAP3 PATL1 FAM83B GAS2L1 MAP7D1 TTBK1 MAP1S CEP170B PCNT	7.27e-09	230	139	13	int:MAPRE3
Interaction	MAPRE1 interactions	FN1 TRIO MAPT APC2 CAMSAP3 PLEKHA4 PATL1 FAM83H BAP1 GAS2L1 MAP7D1 TTBK1 MAP1S SEC16A LSM14A SRRM2 CEP170B PCNT	1.66e-08	514	139	18	int:MAPRE1
Interaction	DYRK1A interactions	ADAM19 FN1 SRSF7 MAPT PLEKHA4 TRIOBP ARHGEF17 PABIR2 CAMKK2 KMT2D SHROOM1 FAM117A GLI1 SEC16A DCHS1 PPP1R18 PCNT	2.68e-07	552	139	17	int:DYRK1A
Interaction	SFN interactions	PABIR1 MAP1A MAPT PAK4 CAMSAP3 ARHGEF17 MAP3K6 PABIR2 FAM83H BAP1 FAM83B PHLDB1 MAP7D1 CAMKK2 SH3PXD2A MAP3K10 SRRM2 CEP170B	1.35e-06	692	139	18	int:SFN
Interaction	YWHAE interactions	PABIR1 KIF21B HIVEP1 FN1 SRSF7 MAPT PAK4 CAMSAP3 PLEKHA4 ANKRD55 PABIR2 FAM83H BAP1 FAM83B PHLDB1 MAP7D1 KANK1 SH3PXD2A MAP3K10 ERC2 LTBP1 SRRM2 RGL2 CEP170B AGAP3	1.46e-06	1256	139	25	int:YWHAE
Interaction	SH3KBP1 interactions	SRRM1 HIVEP1 SRSF7 GGN NELFA KATNB1 GAS2L1 PHLDB1 ATXN2 CASKIN2 SRRM2 SOS1	1.96e-06	315	139	12	int:SH3KBP1
Interaction	YWHAQ interactions	PABIR1 CBLL1 KIF21B FN1 MAPT PAK4 CAMSAP3 PLEKHA4 ANKRD55 PABIR2 FAM83H BAP1 FAM83B PHLDB1 MAP7D1 KANK1 SHROOM1 FAM117A SH3PXD2A MAP3K10 RGL2 UNC79 CEP170B	2.37e-06	1118	139	23	int:YWHAQ
Interaction	KPTN interactions	ADAM19 SZT2 APC2 VWCE NFRKB	5.85e-05	60	139	5	int:KPTN
Interaction	PNMA2 interactions	FAM110D PAK4 KATNB1 CAMSAP3 KDM6B FAM83B MAP7D1 RIMBP3C CEP170B	6.27e-05	251	139	9	int:PNMA2
Interaction	TRIM36 interactions	MAP1A MAPT PAK4 CAMSAP3 MAP7D1 MAP1S CEP170B	6.39e-05	144	139	7	int:TRIM36
Interaction	GAN interactions	KIF21B SRSF7 RELA ZZEF1 ZNF469 PHLDB1 TENM3 CACNA1H PCNT	6.67e-05	253	139	9	int:GAN
Interaction	SMG7 interactions	HIVEP1 PLEKHA4 PATL1 RBM20 KMT2D ATXN2 YLPM1 SEC16A RPRD2 LSM14A	7.54e-05	319	139	10	int:SMG7
Interaction	XRN1 interactions	KATNB1 PLEKHA4 PATL1 PLEKHG2 ATXN2 SEC16A CC2D2A LSM14A SRRM2	7.75e-05	258	139	9	int:XRN1
Interaction	SEPTIN9 interactions	FN1 PLEKHA4 MCL1 BAP1 ARMC5 PPP1R18 LSM14A SRRM2 PCNT	9.50e-05	265	139	9	int:SEPTIN9
Cytoband	Ensembl 112 genes in cytogenetic band chr2p22	SRSF7 BIRC6 LTBP1 SOS1	3.17e-04	104	142	4	chr2p22
Cytoband	17p13.2	CAMTA2 ZZEF1 INCA1	6.76e-04	55	142	3	17p13.2
Cytoband	Ensembl 112 genes in cytogenetic band chr17p13	CAMTA2 KDM6B ZZEF1 ARHGEF15 INCA1 PIK3R5	7.61e-04	346	142	6	chr17p13
Cytoband	19p13.3	TICAM1 APC2 CACTIN-AS1 PWWP3A MADCAM1	8.87e-04	237	142	5	19p13.3
Cytoband	1p36.11	SRRM1 FAM110D MAP3K6	1.25e-03	68	142	3	1p36.11
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TRIO PLEKHG2 ARHGEF17 ARHGEF15 SOS1	7.87e-06	66	75	5	722
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHA4 TRIOBP PLEKHG2 PHLDB1 AGAP3 SOS1	2.13e-04	206	75	6	682
GeneFamily	INO80 complex \|SRCAP complex	INO80D NFRKB	1.72e-03	15	75	2	595
GeneFamily	Ankyrin repeat domain containing	ANKRD55 KANK1 CASKIN2 ANKRD34C AGAP3	3.32e-03	242	75	5	403
GeneFamily	Fibronectin type III domain containing	FN1 IGDCC4 FNDC1 LRIT1	4.41e-03	160	75	4	555
GeneFamily	Mitogen-activated protein kinase kinase kinases\|RAF family	MAP3K6 MAP3K10	4.42e-03	24	75	2	654
GeneFamily	Ataxins\|Trinucleotide repeat containing	KMT2D ATXN2	4.79e-03	25	75	2	775
Coexpression	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	ONECUT2 MAPT NACA CAMSAP3 TESK1 KMT2D ATXN2 SEC16A SRRM2 RGL2 INPP5J	6.04e-06	385	137	11	M2840
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADAM19 ARHGEF17 RBM20 LDB3 SHROOM1 NKD1 DCHS1 MAP3K10 CACNA1H	2.68e-09	163	141	9	8f24cef152f5965727bbeee116bd26c75cbba82a
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2\|TCGA-Kidney / Sample_Type by Project: Shred V9	ADAM19 FN1 PLEKHG2 MEF2C FNDC1 SH3PXD2A DCHS1 HHIPL1	1.45e-07	186	141	8	1e6526fc9e9381b7ace864588cc7bd80194338d6
ToppCell	PBMC-Mild-cDC_6\|Mild / Compartment, Disease Groups and Clusters	ABCC4 FN1 ANKRD55 SHROOM1 MAP1S DCHS1 LTBP1	6.74e-07	156	141	7	3db686849844120b3e376599929d11ad06f0d577
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF21B ONECUT2 MAP1A CAMSAP3 KANK1 GLI1 UNC79	1.69e-06	179	141	7	b44e2d53b82c3c141bfc6539054b19708200a0d9
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 MAP1A GGN FNDC1 NKD1 LINC00304 HHIPL1	1.82e-06	181	141	7	c6d2a13df3b74fade3b0c71e285b4c14c8e52413
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 MAP1A GGN FNDC1 NKD1 LINC00304 HHIPL1	1.82e-06	181	141	7	c62b0a2422377ffadaab63edd538e87a06fa5017
ToppCell	Pericytes-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	MAP1A RBM20 LDB3 NKD1 LINC00304 CACNA1H LTBP1	1.96e-06	183	141	7	4617b18da8d699a44e4c47980197b1e7eb951470
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGEF17 MEF2C RBM20 LDB3 NKD1 CACNA1H LTBP1	2.43e-06	189	141	7	127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGEF17 MEF2C RBM20 LDB3 NKD1 CACNA1H LTBP1	2.43e-06	189	141	7	2cfb4d12f75678d1619f4743838a0e954bd57761
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 ARHGEF17 FNDC1 LDB3 NKD1 TENM3 LTBP1	2.51e-06	190	141	7	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	HIVEP1 MED13L NKD1 ATXN2 SRRM2 MED13 SOS1	2.69e-06	192	141	7	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	IPF-Myeloid-cDC2\|IPF / Disease state, Lineage and Cell class	ABCC4 ADAM19 PLEKHG2 MEF2C NKD1 LTC4S PIK3R5	2.69e-06	192	141	7	fe1de692fec48cba4a9bbc6eaa257260e8b4e800
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	HIVEP1 MED13L NKD1 ATXN2 SRRM2 MED13 SOS1	2.79e-06	193	141	7	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	IPF-Myeloid-cDC2\|Myeloid / Disease state, Lineage and Cell class	CASS4 ABCC4 ADAM19 PLEKHG2 MEF2C NKD1 LTC4S	2.89e-06	194	141	7	accf4b7b09e2048f2e47a52201e0158684dda8fe
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	FN1 MAP1A MEF2C FNDC1 ZNF469 TENM3 SORCS2	2.89e-06	194	141	7	55b97095a7a17a312c616703d291738a0f806339
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAM19 FN1 RBM20 LDB3 NKD1 CACNA1H LTBP1	3.19e-06	197	141	7	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	SRRM1 MCL1 RSRC2 KDM6B KMT2C GNAS SRRM2	3.19e-06	197	141	7	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	SRRM1 MCL1 RSRC2 KDM6B KMT2C GNAS SRRM2	3.30e-06	198	141	7	44417089b62056269cac38d3134ff209c05b7007
ToppCell	Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FN1 FNDC1 LDB3 NKD1 ERC2 CACNA1H LTBP1	3.30e-06	198	141	7	1e1ea54f0c234f3b6d29064c4881d8a0c0949a75
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SRRM1 MCL1 RSRC2 KDM6B KMT2C GNAS SRRM2	3.30e-06	198	141	7	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FN1 PLEKHA4 ARHGEF17 SH3PXD2A GLI1 LTBP1 HHIPL1	3.41e-06	199	141	7	fbec5c034576cb1adaf05f6f97cc5525d19e0c1b
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 FAM110D MAP3K6 MEF2C ARHGEF15 CASKIN2 DCHS1	3.41e-06	199	141	7	da5a88749d859d535daa030d0974485906cc0ba7
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAM19 RBM20 FNDC1 LDB3 NKD1 CACNA1H LTBP1	3.53e-06	200	141	7	a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 FAM110D MAP3K6 MEF2C ARHGEF15 CASKIN2 DCHS1	3.53e-06	200	141	7	ced14d83222dbebca85c40540e76824e683354f3
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / Treatment groups by lineage, cell group, cell type	FN1 MEF2C ARHGEF15 CASKIN2 LTBP1 LTC4S GNAS	3.53e-06	200	141	7	b17eb1587ca86c3d40515128a00a8d8fd787fccf
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma\|TCGA-Breast / Sample_Type by Project: Shred V9	FHIP1B SHROOM1 GLI1 PWWP3A LTC4S RGL2	1.01e-05	155	141	6	a4f2fffa8d0de760c556c3f8f1c91804eedbfa68
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF21B TRIO PAK4 PABIR2 RIMBP3 KANK1	1.40e-05	164	141	6	0853e75b60b2a78257b660910c3ee15b09c5f5b0
ToppCell	3'_v3-bone_marrow-Mast-Mast_cell_lympho\|bone_marrow / Manually curated celltypes from each tissue	MAP1A TRIO MED13L PNPLA6 LTBP1 LTC4S	1.71e-05	170	141	6	4dedf482cd4521b3f87d2b5ae80f7a3ea8686a15
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FN1 SYT17 KATNB1 TRIOBP PHLDB1 DCHS1	1.95e-05	174	141	6	1d157f7a919c8246e83d8060d2a0017c6c781ef3
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-plasma_cell-plasma_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ONECUT2 ANKRD55 SHISA7 FAM117A CACNA1H INCA1	2.02e-05	175	141	6	28b29f844fa46fe579ddc19039fb2d9dc5f48f3b
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-plasma_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ONECUT2 ANKRD55 SHISA7 FAM117A CACNA1H INCA1	2.02e-05	175	141	6	ac96ca9ca309b0d72a2f5af6a3b02c7f80755750
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHG2 ARHGEF17 MEF2C LDB3 NKD1 LTBP1	2.15e-05	177	141	6	4943d040eee0f9dceaddc7498171281d170e271f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHG2 ARHGEF17 MEF2C LDB3 NKD1 LTBP1	2.15e-05	177	141	6	3f2272b577c862dba8ccfb41184054bbd0ace6f5
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGEF17 MEF2C RBM20 LDB3 CACNA1H LTBP1	2.15e-05	177	141	6	a8625d14682183cf77cb51eaf11bc15a3528f586
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MEF2C ORC1 LDB3 TENM3 SORCS2 LTBP1	2.15e-05	177	141	6	4553ee8cd9c24db6511b09fe49ed11a89e7cde9e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGEF17 MEF2C RBM20 LDB3 CACNA1H LTBP1	2.15e-05	177	141	6	3645e2f4a48283f290f85c49c3e79e3f58ac9aa6
ToppCell	facs-Large_Intestine-Proximal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A PNPLA6 NKD1 LTC4S PIK3R5 INPP5J	2.22e-05	178	141	6	09a215a0d6e98e4bb920cabda12af08ff4de3c98
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCC4 MAPT ARHGEF17 ERC2 CACNA1H KISS1	2.67e-05	184	141	6	327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ONECUT2 TCERG1L HCN4 ERC2 SRRM3 UNC79	2.84e-05	186	141	6	b45cce768e4bf91da194fd9660cab7520dfb15ac
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGEF17 MEF2C RBM20 LDB3 NKD1 LTBP1	2.93e-05	187	141	6	ec4b694487cc446999c7b27b119950a4f252c4b3
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGEF17 MEF2C RBM20 LDB3 NKD1 LTBP1	2.93e-05	187	141	6	530e4e6d91b5c0d9aa4543caa2b734a1674c5788
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADAM19 FNDC1 LDB3 PHLDB1 NKD1 LTBP1	3.02e-05	188	141	6	4d1e5f85342ae550086609d7680e32730b78b5d2
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	FAM110D ARHGEF15 IGDCC4 SHROOM1 GLI1 SORCS2	3.02e-05	188	141	6	c90669b51e1902fe7726555290c91c92a911df83
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHG2 ARHGEF17 MEF2C LDB3 NKD1 LTBP1	3.11e-05	189	141	6	fac5c291a9a87418bb0878c3d624829bdbf1f428
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ADAM19 FNDC1 LDB3 NKD1 SORCS2 LTBP1	3.11e-05	189	141	6	da9ecc0d7b81c1901f30f97bb44112dc85444a66
ToppCell	Mesenchymal-airway_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	ADAM19 FNDC1 LDB3 PHLDB1 NKD1 LTBP1	3.20e-05	190	141	6	645e56b02edc3702c7db917b8ecd5eed0decaf71
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 RBM20 LDB3 SH3PXD2A CACNA1H LTBP1	3.30e-05	191	141	6	04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCell	Mesenchymal-vascular_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	ARHGEF17 MEF2C RBM20 LDB3 CACNA1H LTBP1	3.30e-05	191	141	6	fd89fbc62aa1c73e0f659991e3bd726a0c97bd68
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 PLEKHG2 ARHGEF17 MEF2C LDB3 LTBP1	3.30e-05	191	141	6	7b0d42a877540dbb346a76a62403e0d5d3e07fa6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 PLEKHG2 ARHGEF17 MEF2C LDB3 LTBP1	3.30e-05	191	141	6	cd854b9c426924fdc84bf7f411f6dea447143e79
ToppCell	COPD-Myeloid-cDC2\|Myeloid / Disease state, Lineage and Cell class	CASS4 ABCC4 ADAM19 MEF2C NKD1 LTC4S	3.39e-05	192	141	6	984cdc2f1d93e164bc946d63f58dacb629f82eb7
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FN1 IGDCC4 FNDC1 TENM3 GLI1 LTBP1	3.49e-05	193	141	6	b05361ffe111a38cfa26eb86e4ae62c15ac99b7b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAM19 FN1 FNDC1 NKD1 TENM3 LTBP1	3.70e-05	195	141	6	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAM19 FN1 FNDC1 NKD1 TENM3 LTBP1	3.70e-05	195	141	6	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 FNDC1 LDB3 NKD1 TENM3 LTBP1	3.81e-05	196	141	6	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 FNDC1 LDB3 NKD1 TENM3 LTBP1	3.81e-05	196	141	6	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	(3)_Chondrocytes-(30)_Chondro\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	FN1 VWCE IGDCC4 NKD1 TENM3 GLI1	3.92e-05	197	141	6	a07ab2564ca7d577fd47f444dd7b0c25556e9fc4
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ADAM19 MEF2C FNDC1 LDB3 NKD1 LTBP1	4.03e-05	198	141	6	637f11e292b90d86cdc0d0d828eb26f38289c25b
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAM19 FN1 RBM20 LDB3 CACNA1H LTBP1	4.03e-05	198	141	6	bd42c03e384e64f61b02618cf1a5440033bb04b2
ToppCell	mLN-T_cell-Th1\|mLN / Region, Cell class and subclass	SRSF7 MAP1A MCL1 KDM6B SHROOM1 ARMC5	4.03e-05	198	141	6	7627b7c3a248da2bd5e1e6f7c226e5fd0bc92113
ToppCell	mLN-(1)_T_cell-(12)_Th1\|mLN / shred on region, Cell_type, and subtype	SRSF7 MAP1A MCL1 KDM6B SHROOM1 ARMC5	4.03e-05	198	141	6	1fe8257233232b264b9ca630c2d92c509a195353
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 FAM110D MEF2C ARHGEF15 CASKIN2 DCHS1	4.14e-05	199	141	6	8b62d43af8b2ebb4c1b2d068d50beaf35728dbe7
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP1A MAPT LDB3 PHLDB1 SORCS2 TMEM151A	4.14e-05	199	141	6	5d2e85e40b6b52b1809e680b952913d77215b3d0
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP1A MAPT LDB3 PHLDB1 SORCS2 TMEM151A	4.14e-05	199	141	6	9dd4b17fb8c70ab9e126b23b72600463f3db832d
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	TRIO MED13L BIRC6 INO80D KMT2C SOS1	4.14e-05	199	141	6	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-2\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	ARHGEF17 MEF2C LDB3 NKD1 CACNA1H LTBP1	4.14e-05	199	141	6	c8bc05dece8b8a87d4a7a3e8112b924e15217de1
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP1A MAPT LDB3 PHLDB1 SORCS2 TMEM151A	4.14e-05	199	141	6	6fb5f931e6217142de38c1fffc011e63bda4772b
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 FAM110D MAP3K6 MEF2C CASKIN2 DCHS1	4.14e-05	199	141	6	e6715288a586631676722f2323f0d833431161cf
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ADAM19 FN1 SZT2 KMT2C SRRM2 PIK3R5	4.14e-05	199	141	6	379bbd9cecf466b902411c54d74bd9885285b1ba
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAM19 FN1 RBM20 LDB3 CACNA1H LTBP1	4.14e-05	199	141	6	b1753474152b82a0b811b9878c890a359e14919a
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ARHGEF17 MEF2C LDB3 NKD1 CACNA1H LTBP1	4.14e-05	199	141	6	78b245d40c1e169ff2d26907b63d732e34529c5f
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP1A MAPT LDB3 PHLDB1 SORCS2 TMEM151A	4.14e-05	199	141	6	1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ARHGEF17 MEF2C LDB3 NKD1 CACNA1H LTBP1	4.14e-05	199	141	6	8e1e95c3a4b856415af208be6ad977e575bac189
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TRIO BIRC6 MEF2C ARHGEF15 KMT2C PCNT	4.26e-05	200	141	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MAP1A ARHGEF17 MEF2C LDB3 KANK1 LTBP1	4.26e-05	200	141	6	9169a9ec8e9ab95d90a64c5a19ac666a5cf82313
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MAP1A ARHGEF17 MEF2C LDB3 KANK1 LTBP1	4.26e-05	200	141	6	a3a1e35934d676c39f917652e50c502cb2f613c1
ToppCell	Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	GGN PATL1 MEF2C ARHGEF15 GAS2L1 ZNF541	4.26e-05	200	141	6	a8b59e6fe04271fef61db911a286b5c48438bb84
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 FAM110D MEF2C ARHGEF15 CASKIN2 DCHS1	4.26e-05	200	141	6	b1be27d134a8633e3e7862c6a0d7be2001d387f0
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Artery\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FN1 MEF2C ARHGEF15 LTBP1 LTC4S GNAS	4.26e-05	200	141	6	77ae679c35d3b9e2b620f34129f3a8d47e922c65
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 FAM110D MEF2C ARHGEF15 CASKIN2 DCHS1	4.26e-05	200	141	6	dba96cda5f3b780a3d4171b61bc8aaddc1f5d466
ToppCell	Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PDK3 PLEKHA4 PHLDB1 FAM117A SH3PXD2A ARMC5	4.26e-05	200	141	6	f7c3a8f5ac156c05ad7335d6d142c154c7d86449
ToppCell	COVID-19-COVID-19_Mild\|COVID-19 / Disease, condition lineage and cell class	SRRM1 SRSF7 MCL1 KDM6B GNAS SRRM2	4.26e-05	200	141	6	62c25042086f1afd1102e0720e933c2e476468fd
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 FAM110D MEF2C ARHGEF15 CASKIN2 DCHS1	4.26e-05	200	141	6	7a69ad5b6c84f1aebacea5cacb9bc5c63dfd1dac
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_only / Treatment groups by lineage, cell group, cell type	PLEKHA4 ARHGEF17 MEF2C LDB3 KANK1 LTBP1	4.26e-05	200	141	6	7c62678cf408aaaf98d6df0fb27814d2007c4521
ToppCell	Globus_pallidus\|World / BrainAtlas - Mouse McCarroll V32	SZT2 ADCK5 KDM6B PHLDB1 RGL2	5.07e-05	126	141	5	44b63f945d5bedf1a2ca1810e7e100276ea9dd89
ToppCell	primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PAK4 ZNF469 PHLDB1 KANK1 CASKIN2	8.08e-05	139	141	5	a957ea4e581646c76b16b6a7f89579b8c7ac35b6
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-oligodendrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A MAPT PHLDB1 MAP7D1 NFRKB	1.16e-04	150	141	5	afd651c654e715414eff64cf3a37378d057a56a2
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-valve_cells\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XKR4 FAM83B RIMBP3 LDB3 ANKRD34C	1.27e-04	153	141	5	1440f2716fea74e2c3eb2924eba3d63ebd08c997
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADCK5 LDB3 NKD1 GLI1 LTBP1	1.35e-04	155	141	5	cd7d95cbcad248670e531d80bb83c55e36ebc573
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAPT ARHGEF17 RBM20 ERC2 KISS1	1.43e-04	157	141	5	bfec34182f052cf1c0d847ba53ea335d4d1190de
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAP1A FAM83H FNDC1 SHROOM1 INCA1	1.43e-04	157	141	5	f086753b51860e23f1275bd75e8802d2a7d7b70a
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RBM20 LDB3 PROB1 CACNA1H LTBP1	1.48e-04	158	141	5	84c0a215dabf697ada036c2b9592d0c61b5077de
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	GGN KDM6B PHLDB1 EPOP ERC2	1.52e-04	159	141	5	2f6c60ddff2208a68146f9786143d9aefd528840
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GGN KDM6B PHLDB1 EPOP ERC2	1.52e-04	159	141	5	ded4e3626a62fb6334403b7213b467fb7e8131c3
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	KDM6B ANKRD55 MEF2C EPOP LTC4S	1.61e-04	161	141	5	78cc5bc488bc47726195a649946d414e6bfabf94
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHG2 ARHGEF17 MEF2C GNAS KISS1	1.66e-04	162	141	5	c7114e24cb5525abb9780ca3d35dbcc4eabd4b64
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHG2 ARHGEF17 MEF2C GNAS KISS1	1.66e-04	162	141	5	f1851a173d3bcca2981d934161ec85d1cc0af5a2
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHG2 ARHGEF17 MEF2C GNAS KISS1	1.66e-04	162	141	5	5d902bb31e691aea9749617cc88303c2448f24b8
ToppCell	facs-Liver-Non-hepatocytes-24m-Myeloid-neutrophil\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PABIR1 SAP25 MCL1 KDM6B PIK3R5	1.71e-04	163	141	5	abec4389cd88252449f110fe95416d67424b403a
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HCN4 GRID2IP ERC2 SRRM3 UNC79	1.81e-04	165	141	5	4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496
Drug	Methamphetamine	CBLL1 SRRM1 FN1 MAP1A HCN4 MAPT ADCK5 SYT17 CUL9 MCL1 RELA CAMTA2 PLEKHG2 KDM6B ZZEF1 RBM20 ARHGEF15 ORC1 PHLDB1 GLI1 LTBP1 LTC4S SRRM2 RGL2 PIK3R5 ZNF541 PCNT	7.49e-08	1401	138	27	ctd:D008694
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	FN1 MAPT CUL9 INO80D MEF2C ORC1 LSM14A SRRM2 INPP5J	3.46e-06	198	138	9	4448_DN
Disease	ACTH-independent Cushing syndrome	ARMC5 GNAS	1.93e-05	2	130	2	cv:CN294278
Disease	Kleefstra syndrome 2 (implicated_via_orthology)	KMT2C KMT2D	1.93e-05	2	130	2	DOID:0080598 (implicated_via_orthology)
Disease	Cushing syndrome due to macronodular adrenal hyperplasia	ARMC5 GNAS	1.93e-05	2	130	2	cv:C2062388
Disease	eosinophil count	HIVEP1 MAPT SYT17 SCAND2P MCL1 BUD13 RELA ZFPM1 KDM6B LINC00336 ITPKB FNDC1 NKD1 ATXN2 SEC16A PPP1R18 CACNA1H SRRM3 PIK3R5	2.89e-05	1488	130	19	EFO_0004842
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	TRIO SRRM2 MED13	5.43e-05	17	130	3	DOID:0060307 (is_implicated_in)
Disease	Acth-Independent Macronodular Adrenal Hyperplasia	ARMC5 GNAS	5.76e-05	3	130	2	C1857451
Disease	Cushing syndrome	ARMC5 GNAS	1.15e-04	4	130	2	cv:C0010481
Disease	Intrahepatic Cholangiocarcinoma	BAP1 KMT2C GNAS	1.58e-04	24	130	3	C0345905
Disease	Extrahepatic Cholangiocarcinoma	BAP1 KMT2C GNAS	1.58e-04	24	130	3	C3805278
Disease	Cholangiocarcinoma	BAP1 KMT2C GNAS	2.02e-04	26	130	3	C0206698
Disease	Abnormality of the eye	APC2 MED13	3.99e-04	7	130	2	C4316870
Disease	N-acetylcarnosine measurement	ABCC4 ATXN2	5.30e-04	8	130	2	EFO_0022101
Disease	blood molybdenum measurement	XKR4 ATXN2 MADCAM1	6.30e-04	38	130	3	EFO_0007582
Disease	Paroxysmal atrial fibrillation	HCN4 MAPT NACA RBM20 SH3PXD2A	6.52e-04	156	130	5	C0235480
Disease	familial atrial fibrillation	HCN4 MAPT NACA RBM20 SH3PXD2A	6.52e-04	156	130	5	C3468561
Disease	Persistent atrial fibrillation	HCN4 MAPT NACA RBM20 SH3PXD2A	6.52e-04	156	130	5	C2585653
Disease	Liver Diseases, Parasitic	KMT2C GNAS	6.80e-04	9	130	2	C0023897
Disease	Atrial Fibrillation	HCN4 MAPT NACA RBM20 SH3PXD2A	7.31e-04	160	130	5	C0004238
Disease	Neurodevelopmental Disorders	TRIO MED13L MEF2C KMT2C	7.76e-04	93	130	4	C1535926
Disease	coronary artery disease	ADAM19 FN1 HCN4 MCL1 BUD13 ZFPM1 XKR4 ANKRD55 FAM83B FNDC1 MAP1S ATXN2 RPRD2 HHIPL1	8.12e-04	1194	130	14	EFO_0001645
Disease	Intellectual Disability	TRIO APC2 MED13L KDM6B MEF2C KMT2C GNAS MED13	8.47e-04	447	130	8	C3714756
Disease	Parkinson disease, late-onset	MAPT ATXN2	8.47e-04	10	130	2	cv:C3160718
Disease	PARKINSON DISEASE, LATE-ONSET	MAPT ATXN2	8.47e-04	10	130	2	168600
Disease	late onset Parkinson's disease (is_implicated_in)	MAPT ATXN2	1.03e-03	11	130	2	DOID:0060892 (is_implicated_in)
Disease	platelet crit	CASS4 SRRM1 ZNF487 ABCC4 MAP1A ZFPM1 KDM6B MEF2C ATXN2 YLPM1 DCHS1 RPRD2	1.05e-03	952	130	12	EFO_0007985
Disease	neurotic disorder	HIVEP1 MAPT TENM3 YLPM1	1.06e-03	101	130	4	EFO_0004257
Disease	PARKINSON DISEASE, LATE-ONSET	MAPT ATXN2	1.24e-03	12	130	2	C3160718
Disease	disks large homolog 3 measurement	ZFPM1 MEF2C	1.24e-03	12	130	2	EFO_0802472
Disease	tumor necrosis factor receptor superfamily member EDAR measurement	ZFPM1 MEF2C	1.24e-03	12	130	2	EFO_0008310
Disease	QRS-T angle	NACA ZFPM1 RBM20 ERC2	1.26e-03	106	130	4	EFO_0020097
Disease	cortical thickness	MAPT C5orf63 TRIOBP CUL9 MEF2C ZNF469 PHLDB1 ATXN2 SH3PXD2A YLPM1 ERC2 LSM14A AGAP3	1.30e-03	1113	130	13	EFO_0004840
Disease	QRS amplitude, QRS complex	HIVEP1 MAPT RBM20	1.41e-03	50	130	3	EFO_0005054, EFO_0007742
Disease	extracellular matrix protein 1 measurement	MCL1 RPRD2	1.46e-03	13	130	2	EFO_0008126
Disease	coronary artery disease, factor VII measurement	BUD13 MAP1S ATXN2 HHIPL1	1.50e-03	111	130	4	EFO_0001645, EFO_0004619
Disease	IGFBP-3 measurement	CACTIN-AS1 SORCS2 UNC79	1.76e-03	54	130	3	EFO_0004626
Disease	Peripheral Nervous System Diseases	PNPLA6 GLI1 CACNA1H	1.76e-03	54	130	3	C4721453
Disease	Metastatic melanoma	TRIO TTBK1 MAP3K10	1.76e-03	54	130	3	C0278883
Disease	chronotype measurement	HIVEP1 MAPT MED13L BIRC6 MEF2C ITPKB FAM83B KANK1 KMT2D DCHS1 RPRD2	1.85e-03	882	130	11	EFO_0008328
Disease	intraocular pressure measurement	TRIOBP CAMTA2 ZNF469 LDB3 ATXN2 SH3PXD2A LTBP1 CSTPP1	1.92e-03	509	130	8	EFO_0004695
Disease	Barrett Epithelium	MCL1 RELA	2.22e-03	16	130	2	C1258085
Disease	Barrett Esophagus	MCL1 RELA	2.22e-03	16	130	2	C0004763
Disease	renal cell carcinoma (is_marker_for)	FN1 RELA KDM6B KANK1	2.52e-03	128	130	4	DOID:4450 (is_marker_for)
Disease	Cardiomyopathies	MAPT RBM20 LDB3 SOS1	2.66e-03	130	130	4	C0878544
Disease	obesity (implicated_via_orthology)	MAPT MED13L SEC16A DCHS1 MED13	2.69e-03	215	130	5	DOID:9970 (implicated_via_orthology)
Disease	Child Behaviour Checklist assessment	KANK1 TENM3	2.81e-03	18	130	2	EFO_0005661
Disease	FEV/FEC ratio	ADAM19 C5orf63 MCL1 ARHGEF17 FAM83H FAM83B KANK1 SH3PXD2A YLPM1 ERC2 LTBP1 HHIPL1 AGAP3	3.06e-03	1228	130	13	EFO_0004713
Disease	osteoarthritis	MAPT XKR4 GRID2IP RPRD2 LTBP1	3.08e-03	222	130	5	MONDO_0005178
Disease	Chronic myeloproliferative disorder	ORC1 PCNT	3.14e-03	19	130	2	C1292778
Disease	Profound Mental Retardation	MED13L KDM6B MEF2C GNAS	3.39e-03	139	130	4	C0020796
Disease	lung non-small cell carcinoma (is_implicated_in)	MCL1 RELA KMT2C KMT2D	3.39e-03	139	130	4	DOID:3908 (is_implicated_in)
Disease	Mental Retardation, Psychosocial	MED13L KDM6B MEF2C GNAS	3.39e-03	139	130	4	C0025363
Disease	Mental deficiency	MED13L KDM6B MEF2C GNAS	3.39e-03	139	130	4	C0917816
Disease	glomerulonephritis (biomarker_via_orthology)	LTBP1 LTC4S	3.47e-03	20	130	2	DOID:2921 (biomarker_via_orthology)
Disease	triacylglycerol 46:1 measurement	ERC2 ANKRD34C	3.47e-03	20	130	2	EFO_0010401
Disease	Bladder Neoplasm	BAP1 KMT2C KMT2D GLI1	3.48e-03	140	130	4	C0005695
Disease	Malignant neoplasm of urinary bladder	BAP1 KMT2C KMT2D GLI1	3.56e-03	141	130	4	C0005684
Disease	autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis	ANKRD55 NKD1 TENM3	3.69e-03	70	130	3	EFO_0000384, EFO_0000676, EFO_0000729, EFO_0001060, EFO_0002609, EFO_0003898, EFO_0005140, EFO_0006812, MONDO_0005147, MONDO_0007915, MONDO_0015517
Disease	total blood protein measurement	MCL1 ANKRD55 KMT2D ATXN2 SH3PXD2A SEC16A SOS1	3.84e-03	449	130	7	EFO_0004536
Disease	Colorectal Carcinoma	ABCC4 ADAM19 TCERG1L FN1 APC2 KMT2C DCHS1 GNAS PIK3R5	3.99e-03	702	130	9	C0009402
Disease	Seckel syndrome	ORC1 PCNT	4.20e-03	22	130	2	C0265202
Disease	triacylglycerol 48:2 measurement	ERC2 ANKRD34C	4.20e-03	22	130	2	EFO_0010405
Disease	Parkinson disease	MAPT ATXN2	4.20e-03	22	130	2	cv:C0030567
Disease	basophil count, eosinophil count	MCL1 BUD13 ZFPM1 KDM6B ATXN2	4.37e-03	241	130	5	EFO_0004842, EFO_0005090

Protein segments in the cluster

Peptide	Gene	Start	Entry
PGTRRRRSPSSPSHP	C5orf63	66	A6NC05
RSASLPPRTRLPSGS	GNAS	201	P84996
PQSRLTARPSRSPEP	GNAS	266	P84996
LPRATPATAPGTSPR	AGAP3	431	Q96P47
SSPRRVRHGTPDPSP	BUD13	126	Q9BRD0
PPRRIRHDSSDTSPP	BUD13	176	Q9BRD0
VPSTSPSSARRRPPH	ANKRD34C	426	P0C6C1
RAVSATPPRPPSRRG	BIRC6	3926	Q9NR09
RRTTSPSPEPDRLSG	CASS4	386	Q9NQ75
ERTESSRRPPPSRPI	ADAM19	826	Q9H013
RASPPSFPSGSPVLR	FAM117A	191	Q9C073
SSRSSCSQRRPPPPG	CDRT15P3	181	P0DPF6
RPGPPHRTSATLPAR	CAMTA2	1141	O94983
PLRSPIRSANPTRPS	BAP1	506	Q92560
PAPTPTSLRAPRTQR	ARMC5	491	Q96C12
RNVRGLPPRFSSPTP	ADCK5	31	Q3MIX3
SPVSRRSASPEPAPR	ARHGEF15	101	O94989
ASPLRTSRSRPHPPS	ARHGEF15	241	O94989
SRTEPTRPPPSQSSR	ANKRD55	321	Q3KP44
LGSPSPASRTPARPF	CEP170B	476	Q9Y4F5
RSPFTVPPRTPACRS	CACTIN-AS1	26	Q8N1I8
PSPSLRPRPASSISL	DMRTC1;	166	Q5HYR2
SPSPARRVPATRRSP	CAMSAP3	756	Q9P1Y5
STLPDRPSTPPSDLR	IGDCC4	841	Q8TDY8
PPRTSNPTRSRSHEP	NKD1	286	Q969G9
ERPRSRSPVSRSLSP	RBM20	631	Q5T481
DTSTPGSRRLSPPPS	RIMBP3B	316	A6NNM3
DTSTPGSRRLSPPPS	RIMBP3C	316	A6NJZ7
SPETPPTPGALRRRR	ARHGEF17	696	Q96PE2
LSASPASSPGRRPTP	FHIP1B	526	Q8N612
RALPRRSTSPIIGSP	PATL1	171	Q86TB9
RLRLPRPGPSFSTPT	DCHS1	1966	Q96JQ0
LFPSPGLPTRTSPVR	PNPLA6	351	Q8IY17
GRPTTLTFAPRPRPA	MAP3K10	876	Q02779
PPATPRPRISEGFTR	KMT2C	2221	Q8NEZ4
TPRSPGSTRTRRPEI	MADCAM1	281	Q13477
PADRASRAPPRPRST	MAP1A	2636	P78559
LPLAASSIPRPRTPS	MAP1S	626	Q66K74
SSIPRPRTPSPESHR	MAP1S	631	Q66K74
PATPRFSVPTPRTPR	MED13L	1041	Q71F56
FSVPTPRTPRTPRTP	MED13L	1046	Q71F56
PELRPTFSPAFSRPS	LDB3	136	O75112
SSPARSPSPAVPLRV	NFRKB	221	Q6P4R8
VFSPTGNRTPIPPSR	NELFA	231	Q9H3P2
RSTPRPTARAPTRAP	HHIPL1	611	Q96JK4
PTRASPLGARASPPR	ATXN2	121	Q99700
SFRRPESPRPRVSFP	KDM6B	621	O15054
SISRTPPRRSEPFPA	KATNB1	391	Q9BVA0
VTPERRPTSSPRPTS	FAM83B	906	Q5T0W9
RSRSPSSPRHAPRPS	MAP3K6	911	O95382
SPGVPSERTRRTSKP	LTBP1	76	Q14766
RAFRVSPPLTTGPPE	LTC4S	31	Q16873
REPSAFTLPPPRRSS	EPS8L3	216	Q8TE67
FTPPSSPPTRPRNDR	KIF21B	1236	O75037
PSRTPSPRSPAPARV	ZFPM1	486	Q8IX07
PVLAPSRERPPSSSS	ONECUT2	306	O95948
RRKPSVPCPEPRTTS	KANK1	66	Q14678
TARLSRRGTSLSPPP	KISS1	61	Q15726
AVGRRSPVSTRPLPS	LSM14A	211	Q8ND56
SPPRDRTTTPSRYPQ	MEF2C	396	Q06413
SRRSSLASPFPPGSP	GLI1	556	P08151
LEGSPSRSPRLPRSP	ERC2	11	O15083
RRITPALATPASPPT	GGN	186	Q86UU5
SRTPGPRPPRSTLRM	LINC00336	61	Q6ZUF6
PPSPIPSPTTRFTTR	PABIR1	171	Q96E09
QSPPRTRESPPTRDV	PCNT	3241	O95613
LPSAPTPLRPGFSRT	CASKIN2	356	Q8WXE0
RSIRLRPLPSPSPSA	HCN4	46	Q9Y3Q4
TLPPASIPPDTSRLR	LRIT1	51	Q9P2V4
PSPVPSPRRFSRRSQ	PABIR2	136	Q7Z309
PPPPRSVSQETFRIS	CBLL1	271	Q75N03
PPVPGTPTLRNRTFS	ABCC4	641	O15439
ASTPPLPRRAPRTVS	ORC1	426	Q13415
PSPGERPARRTTSES	APC2	2066	O95996
RPARRTTSESPSRLP	APC2	2071	O95996
PDPTRPPSRRKLFTF	GRID2IP	656	A4D2P6
PRSLPPIPSTSRTGF	CC2D2A	81	Q9P2K1
ASCLPSRTPPRVGSP	CSTPP1	291	Q9H6J7
RFLTRRPPASSPEDP	LINC00304	76	Q8N9R0
RTAQPRRPAPTLPTT	EPOP	296	A6NHQ4
TTPPTTATPIRHRPR	FN1	2151	P02751
ERPSRRLTTGTPASP	GAS2L1	381	Q99501
RLTTGTPASPRRPPA	GAS2L1	386	Q99501
TPASPRRPPALRSQS	GAS2L1	391	Q99501
SPRASHVPSRLPPRS	FNDC1	1251	Q4ZHG4
ARPPRRSSQPSPTAV	MAP7D1	106	Q3KQU3
LLPSSRAPTVDPPRT	INO80D	266	Q53TQ3
VSSPQSSPRLPRRPT	CAMKK2	131	Q96RR4
RSPAPSPVLPSSSLR	CUL9	1456	Q8IWT3
RRGSPVPPVPERRSS	FAM83H	911	Q6ZRV2
QSPPRSPRPASVRTR	CACNA1H	2056	O95180
TFTVNPRRSVPPATP	PPP1R18	471	Q6NYC8
STRSPPPGRDESYPR	RPRD2	766	Q5VT52
PSTLTPDSRRVARPP	MCL1	66	Q07820
PRVLSPPTTKRRTSP	PCARE	1036	A6NGG8
RSNSLRRDSPPPPAR	PAK4	96	O96013
CSRVVSRSPPPRLPS	INCA1	16	Q0VD86
PSTFTVQQPPPSRRR	PGBD3	91	Q8N328
PSSRIFTPGFRPTPA	FAM66E	16	P0C841
PGPRESVTPRSTARL	PWWP3A	331	Q2TAK8
ARVLPRPSPSRGPST	SAP25	121	Q8TEE9
LVPLRPPSPARSTSR	SZT2	2931	Q5T011
LSPPASSPRPSRGHR	RGL2	601	O15211
RRFSRSLSRTPSPPP	RSRC2	211	Q7L4I2
SLSRTPSPPPFRGRN	RSRC2	216	Q7L4I2
RSGRRSSPSPPPSEE	SNX11	186	Q9Y5W9
PRPAPPRGSSRSLSR	SRRM3	411	A6NNA2
LPRTPSRRSRSGSSP	SRRM2	1431	Q9UQ35
QTPRPRSRSPSSPEL	SRRM2	1491	Q9UQ35
PLTPRTNSPDGRRSS	SYT17	81	Q9BSW7
DTSTPGSRRLSPPPS	RIMBP3	316	Q9UFD9
RARSPDLFTPLSRPP	PLEKHA4	226	Q9H4M7
PPRRAVLSPGSVFSP	ITPKB	36	P27987
LPPPRPTRKRSLSSD	SORCS2	1021	Q96PQ0
TSPRPRPAVAARSGP	SHROOM1	81	Q2M3G4
PGTRPDRARSSSLTP	SHISA7	236	A6NL88
PARPSGPRLPFSRSR	TMEM151A	391	Q8N4L1
TPRFPTPRTPRTPRT	MED13	1006	Q9UHV7
SEVPSRAVRPRSPSP	PROB1	381	E7EW31
PREPVRTPDVFSSSP	SOS1	1216	Q07889
STAPRPSLEPTRAAP	PDK3	306	Q15120
PSTPSRGRTPSAVER	FAM110D	6	Q8TAY7
GSPLPPRTSARTPER	TRIOBP	1391	Q9H2D6
TSPDPRLSPSFRARP	INPP5J	271	Q15735
SLSRPAPASRPLPTV	TCERG1L	201	Q5VWI1
VAATSPPRPSTAARP	ZFP92	396	A6NM28
RAPPDSPTTPVRSLR	TTBK1	436	Q5TCY1
PSSRASHSSERPPPR	SEC16A	1221	O15027
PVSPPSRAQRSRSLP	PIK3R5	466	Q8WYR1
SPNLRTRPPPRRESS	SH3PXD2A	421	Q5TCZ1
SRRTSTLTRPKVPPP	SH3PXD2A	511	Q5TCZ1
PPSSALPSGTRSLPR	TICAM1	166	Q8IUC6
RHSPSPRPRAPQTSS	SRRM1	681	Q8IYB3
PSPKRSRSPSGSPRR	SRSF7	216	Q16629
PRASPRTPSRASPTR	nan	76	Q9UF83
ASPTRTPPRESPRMS	nan	176	Q9UF83
HRASPTRTPPRASPT	nan	191	Q9UF83
RASPTRRPPRASPTG	nan	236	Q9UF83
PRASPRTPPRASPTT	nan	261	Q9UF83
RTPPRASPTTTPSRA	nan	266	Q9UF83
PPRASLTRTPPRASL	nan	421	Q9UF83
LTRTPPRASLTRTPP	nan	426	Q9UF83
TRTPPRASLTRTPPR	nan	436	Q9UF83
AGVRTTRLPSPTPRL	VWCE	311	Q96DN2
RPTAPSTPSSRPPRI	XKR4	576	Q5GH76
ARPSGRTPPAQLRSP	SCAND2P	136	Q9GZW5
RSRTPSLPTPPTREP	MAPT	526	P10636
PPTRPLPRNTLSRSA	TENM3	281	Q9P273
PSATLPRPDPRLSRS	TESK1	341	Q15569
TRTPPRASLTRSPPT	nan	26	A8MUU9
PPTASLTRTPPRASL	nan	286	A8MUU9
LTRTPPRASLTRSPP	nan	291	A8MUU9
TRSPPRASLTRTPPT	nan	301	A8MUU9
PPRASLTRSPPRASL	nan	331	A8MUU9
LTRTPPRASLTRTPP	nan	381	A8MUU9
TRTPPRASLTRSPPT	nan	391	A8MUU9
PPRASLTRTPPRASL	nan	421	A8MUU9
RRALSPLPTRTTPDP	PHLDB1	466	Q86UU1
SPLPRTRSGPLPSSS	PHLDB1	971	Q86UU1
VRPSAPPARSSVPVT	YLPM1	1526	P49750
SFPSRSPAPERLPAR	ZNF469	3741	Q96JG9
PLSPSTPTRRPPFTR	ZZEF1	1516	O43149
PPLGSPRPRDARSFT	PLEKHG2	446	Q9H7P9
PRPASSPARSESRSP	nan	56	Q6ZS46
PPPRRIAVPSRSSAS	RELA	326	Q04206
SSTPSSAAGPRPPRL	ZNF580	36	Q9UK33
VSPPTPFARRLPSTE	HIVEP1	686	P15822
PSTSRSRPSRIPQPV	TRIO	2331	O75962
QARPRPRPHSGLSTP	nan	236	Q6ZQT7
MASRPRPRTPSRGPS	ZNF487	1	B1APH4
PSSLRSLVPPEARSP	ZNF541	251	Q9H0D2
QSPFRSPLRSPFRSP	UNC79	761	Q9P2D8
RSLPSDPFSRVPASP	KMT2D	2401	O14686
VPATPSSRRDPIAPT	NACA	1516	E9PAV3